CORDIS
EU research results

CORDIS

English EN

Research Infrastructures for Phenotyping, Archiving and Distribution of Mouse Disease Models - Promoting International Cooperation and User Engagement to Enhance Biomedical Innovation

Project information

Grant agreement ID: 653961

Status

Closed project

  • Start date

    1 June 2015

  • End date

    30 November 2019

Funded under:

H2020-EU.1.4.3.2.

  • Overall budget:

    € 1 109 863,75

  • EU contribution

    € 1 103 613,75

Coordinated by:

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

Germany

Objective

The IPAD-MD project addresses cooperation and coordination between the pan-European INFRAFRONTIER Research Infrastructure and complementary research infrastructures in America, Asia and Australia, contributing to the global effort of the International Mouse Phenotyping Consortium (IMPC). In order to increase the reach of INFRAFRONTIER, IPAD-MD will also reach out to complementary infrastructures and user communities in Africa.
IPAD-MD will organise a series of workshops to achieve three major objectives:

1) Strengthen the coordination between the global research infrastructures. A particular focus of IPAD-MD will be to improve global access to the common resources created by INFRAFRONTIER and the IMPC and to align the scientific strategy with international research agendas.
2) Promote the involvement of the key international stakeholders to improve the resources and services offered by INFRAFRONTIER and established in the context of the IMPC. IPAD-MD will involve funders and program offices in the discussions about the future of the resources and services developed in INFRAFRONTIER and the IMPC.
3) Coordinate globally the development of innovative technology solutions for the improvement of the resources and services provided by INFRAFRONTIER and the IMPC. Importantly, the development of related quality control measures to sustain the high quality standards established in INFRAFRONTIER and in the IMPC, ensuring the reproducibility of results.

The outcomes of the IPAD-MD workshops will be made available in reports and in key publications in scientific journals and on the INFRAFRONTIER and IMPC websites. A dedicated Communications & Dissemination Group will ensure the outreach to the wider scientific community and to the general public. The IPAD-MD will improve the quality and global accessibility of high-quality resources and services enabling the biomedical research community to tackle the global health challenges.

Coordinator

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

Address

Ingolstadter Landstrasse 1
85764 Neuherberg

Germany

Activity type

Research Organisations

EU Contribution

€ 793 000

Participants (11)

INFRAFRONTIER GMBH

Germany

EU Contribution

€ 221 250

CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE

France

EU Contribution

€ 12 187,50

UNITED KINGDOM RESEARCH AND INNOVATION

United Kingdom

EU Contribution

€ 12 000

MEDICAL RESEARCH COUNCIL

United Kingdom

USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE

Czechia

EU Contribution

€ 9 658,75

Toronto Centre for Phenogenomics Inc.

Canada

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 12 428,75

GENOME RESEARCH LIMITED

United Kingdom

EU Contribution

€ 6 250

CONSIGLIO NAZIONALE DELLE RICERCHE

Italy

EU Contribution

€ 10 138,75

UNIVERSIDAD AUTONOMA DE BARCELONA

Spain

EU Contribution

€ 10 937,50

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

EU Contribution

€ 15 762,50

Project information

Grant agreement ID: 653961

Status

Closed project

  • Start date

    1 June 2015

  • End date

    30 November 2019

Funded under:

H2020-EU.1.4.3.2.

  • Overall budget:

    € 1 109 863,75

  • EU contribution

    € 1 103 613,75

Coordinated by:

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

Germany